BOVNF Message Board Post 9880458 | Bioinvent Ab
home / stock / bovnf / bovnf message board
pauldgreen
(investorshub)
Posted on: Jan/28/2021 14:25:41
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161281940
BioInvent and Transgene receive CTA approval for Phase
News, Short Squeeze, Breakout and More Instantly...
Bioinvent Ab Company Name:
BOVNF Stock Symbol:
Market:
-
First data for the SC arm : 1 complete response (CR), 2 partial response (PR), 1 stable disease (SD) out of 4 evaluable patients. Further updates from the IV arm; a fifth CR has been observed, adding to a total of 5 CR, 1 PR and 6 SD out of 17 evaluable patients. Data to be presented at ...
-
LUND, SWEDEN / ACCESSWIRE / May 3, 2024 / BioInvent International (STO:BINV) The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) resolved to elect Laura Lassouw-Polman as new Board member, to re-elect the Board members Natalie Berner, Kristoffe...
-
The two poster presentations will report - first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy arm combination data from the Phase 1/2a study with BI-1206 in combin...